SEC Form 4 · accession 0001562180-18-003165
Avalo Therapeutics, Inc. · AVTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Isaac Blech
Director
Period of report
Jun 29, 2018
Accepted (ET)
Jul 2, 2018 · 5:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001534120
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $4.34 | Jun 29, 2018 | A | 6,881 | A | Jun 29, 2018 | Jun 29, 2028 | Common Stock | 6,881 | 6,881 | D |